Identification of oestrogen, progesterone receptor and human epidermal growth factor receptor 2 expression in mediastinal metastases of breast cancer obtained by endobronchial ultrasound-guided transbronchial needle aspiration

P. Serra, J. Sanz-Santos, E. Castellà, B. Cirauqui, F. Andreo, M. Llatjós, M. Avila, M. Margelí, L. Serrano, C. Centeno, V. Quiroga, M. Torky, J. Ruiz-Manzano

Research output: Contribution to journalArticleResearchpeer-review

Abstract

© 2017 John Wiley & Sons Ltd Background: In breast cancer patients, the expression statuses of oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are crucial in the choice of treatment. Receptor expression in metastatic lesions can differ from the primary tumour. The aim of our study was to analyse the utility of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to obtain samples allowing the identification of ER, PR and HER2 expression in patients with mediastinal metastases of breast cancer. Patients and methods: The clinical files of all patients with a final diagnosis of breast cancer mediastinal metastases diagnosed by EBUS-TBNA in our institution were retrospectively analysed. The ability of EBUS-TBNA to obtain samples that allowed hormone receptor and HER2 expression analysis was calculated. Results: Twenty-four patients were included. ER, PR and HER2 assessments could be performed in 22, 20 and 22 patients, respectively. In 20 of the 24 patients it was possible to investigate all three types of receptor expression. In the remaining four cases, where ER, PR or HER2 expression tests could not be performed, it was due to a lack of tissue. In cases with adequate results for EBUS-TBNA and the primary tumour agreement was greater for ER (16/19) and HER2 (12/14) than PR (8/17). Based on receptor status, there was a change in the choice of treatment for five patients. Conclusion: In patients with breast cancer mediastinal metastases, ER, PR and HER2 expression can be assessed in samples obtained by EBUS-TBNA whenever a sufficient tissue sample is collected.
Original languageEnglish
Pages (from-to)35-40
JournalCytopathology
Volume29
Issue number1
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • HER2
  • breast cancer
  • endobronchial ultrasound
  • oestrogen receptor
  • progesterone receptor

Fingerprint Dive into the research topics of 'Identification of oestrogen, progesterone receptor and human epidermal growth factor receptor 2 expression in mediastinal metastases of breast cancer obtained by endobronchial ultrasound-guided transbronchial needle aspiration'. Together they form a unique fingerprint.

Cite this